Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • lre1234
    Senior Member
    • Aug 2011
    • 110

    #16
    As some one who did a solely molecular biology based PhD and has since transferred into the computational world, I think that this site is somewhat biased towards the bioinformatics people. (this is not necessarily a bad thing, and it has been exceedingly helpful to me over the past few years.) But, one thing I have noticed is that many bioinformaticians do not always understand the finer points of a lab experiment. Not in terms of the concept of using biological or technical replicates, but the physical act of doing cell culture, western blots, etc. I have met some people, who would look at a paper in Cell for example, and see 7 figures of western blots, and just think that al you have to do is buy an antibody and it's done, when in reality there is lots of optimization and other work behind all of that. The same goes for the lab people who think that analyzing a number of sequence datasets is just a click away.

    So, no 1 person can do it all, and good communication between all parties is need.

    As a side and maybe unrelated note, I think that one problem is that in many if not the majority of papers that come out, the data analysis sections are rather poorly described, and just give a reference to an older paper, especially when something custom or unique was done. Maybe there should be better standards on how to present the methods on how data was analyzed, which may give a better explanation to the lab people. The same goes the other way, better description of methods for the lab people. Who knows, this may fix the lack of reproducibility in many papers!

    Comment

    • Jessica_L
      Senior Member
      • Feb 2010
      • 117

      #17
      Originally posted by lre1234 View Post
      ...I think that this site is somewhat biased towards the bioinformatics people. (this is not necessarily a bad thing, and it has been exceedingly helpful to me over the past few years.) But, one thing I have noticed is that many bioinformaticians do not always understand the finer points of a lab experiment.
      I was just having a variation on this conversation the other day. I said then, as I'll say now, that I think it's been a natural progression over time. Way back when, none of the protocols were nailed down and Illumina was constantly changing reagents and preps to address performance issues. There was a lot of discussion here about best practices or does-your-data-look-better-with-the-new-chemistry, etc. A lot of those forums settled down as performance issues were worked out.

      While a lot of the wet lab work was eventually simplified into kits, the way data gets processed hasn't been that straightforward or static-- you might adjust the way data is trimmed based on your run QC metrics, or you might want to adjust a filter in a variant caller if you're interested in novel variant detection for a particular sample. Questions come up around how to do that, or the best practices for doing so. Then there are people like me that have been doing the bench work for years and there's a lot to learn on the analysis end, so we ask questions. Also, Illumina used to have next to zero technical support for bioinformatics/pipeline problems, so we came here for answers; now most analysis has shifted to open tools like tophat/bowtie/cufflinks or BBTools or SAMTools and if we have issues, we still come here for answers.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...